Endocrine Hypertension – a Multifaceted Disease

1 Jun Y, Jimmy S, Peter JF. Diagnosing endocrine hypertension: a practical approach. Nephrol 2017;22(9):663–677. JunY JimmyS PeterJF Diagnosing endocrine hypertension: a practical approach Nephrol 2017 22 9 663 677 10.1111/nep.1307828556585 Search in Google Scholar

2 Isabella S, Felix B, Thomas FL. Secondary causes of hypertension. In: Camm AJ, Lüscher TF, Maurer G, Serruys PW, editors. ESC CardioMed. 3rd ed. London: Oxford University Press; 2018; IsabellaS FelixB ThomasFL Secondary causes of hypertension In: CammAJ LüscherTF MaurerG SerruysPW editors. ESC CardioMed 3rd ed. London Oxford University Press 2018 Search in Google Scholar

3 Reena MT, Ewa R, Prapimporn CS, Leonor C, Endocrine hypertension: An overview on the current etiopathogenesis and management options. World J Hypertens 2015;5(2):14–27. ReenaMT EwaR PrapimpornCS LeonorC Endocrine hypertension: An overview on the current etiopathogenesis and management options World J Hypertens 2015 5 2 14 27 10.5494/wjh.v5.i2.14458278926413481 Search in Google Scholar

4 William FY, David AC, Jacques WML, Michael S, Stephen CT. Screening for endocrine hypertension: an endocrine society scientific statement. Endocr Rev 2017;38(2):103–22. WilliamFY DavidAC JacquesWML MichaelS StephenCT Screening for endocrine hypertension: an endocrine society scientific statement Endocr Rev 2017 38 2 103 22 10.1210/er.2017-00054 Search in Google Scholar

5 Er LK, Wu VC. Call for screening for primary aldosteronism: an underdiagnosed and treatable disease, J Thorac Dis 2018;10(2):557–9. ErLK WuVC Call for screening for primary aldosteronism: an underdiagnosed and treatable disease J Thorac Dis 2018 10 2 557 9 10.21037/jtd.2018.01.71586468929607111 Search in Google Scholar

6 Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffallo F, et.al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 2017;69(14):1811–20. MonticoneS BurrelloJ TizzaniD BertelloC ViolaA BuffalloF Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice J Am Coll Cardiol 2017 69 14 1811 20 10.1016/j.jacc.2017.01.05228385310 Search in Google Scholar

7 Born-Frontsberg E, Reincke M, Rump LC, Lorenz R, Hahner S, Diederich S. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metabol 2009;94(4):1125–30. Born-FrontsbergE ReinckeM RumpLC LorenzR HahnerS DiederichS Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry J Clin Endocrinol Metabol 2009 94 4 1125 30 10.1210/jc.2008-211619190103 Search in Google Scholar

8 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et.al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 2016;101(5):L1889–916. FunderJW CareyRM ManteroF MuradMH ReinckeM ShibataH The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society clinical practice guideline J Clin Endocrinol Metabol 2016 101 5 L1889 916 10.1210/jc.2015-406126934393 Search in Google Scholar

9 Zhou Y, Zhang M, Ke S, Liu L. Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis. BMC Endocr Disord 2017;17(1):61. ZhouY ZhangM KeS LiuL Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis BMC Endocr Disord 2017 17 1 61 10.1186/s12902-017-0209-z562739928974210 Search in Google Scholar

10 Kounatiadis P, Petroglou D, Kolettas V, Karvounis H, Primary aldosteronism of late onset: a case report. HIPPOKRATIA 2014;18(2):180–82. KounatiadisP PetroglouD KolettasV KarvounisH Primary aldosteronism of late onset: a case report HIPPOKRATIA 2014 18 2 180 82 Search in Google Scholar

11 Yu R, Furmark L, Wong C, Cardiac abnormalities associated with pheochromocytoma and other adrenal tumors. Endocr Pract 2009;15(1):10–16. YuR FurmarkL WongC Cardiac abnormalities associated with pheochromocytoma and other adrenal tumors Endocr Pract 2009 15 1 10 16 10.4158/EP.15.1.1019211391 Search in Google Scholar

12 Tsirilin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA, Pheochromocytoma: a review. Maturitas 2014;77(3):229–38. TsirilinA OoY SharmaR KansaraA GliwaA BanerjiMA Pheochromocytoma: a review Maturitas 2014 77 3 229 38 10.1016/j.maturitas.2013.12.00924472290 Search in Google Scholar

13 Guerrero MA, Schreinermakers JM, Vriens MR, et al. Clinical spectrum of pheochromocytoma. J Am Coll Surg 2009;209(6):727. GuerreroMA SchreinermakersJM VriensMR Clinical spectrum of pheochromocytoma J Am Coll Surg 2009 209 6 727 10.1016/j.jamcollsurg.2009.09.02219959041 Search in Google Scholar

14 Kassim TA, Clarke DD, Mai VQ, et al. Catecholamine-induced cardiomyopathy. Endocr Pract 2008;14(9):1137–49. KassimTA ClarkeDD MaiVQ Catecholamine-induced cardiomyopathy Endocr Pract 2008 14 9 1137 49 10.4158/EP.14.9.113719158054 Search in Google Scholar

15 Chioncel V, Adam F, Sinescu I, Păun D, Sinescu C. Particularitățile clinice și paraclinice la pacienții hipertensivi cu feocromocitom – studiu retrospectiv. Rom J Cardiol 2012:22(2). ChioncelV AdamF SinescuI PăunD SinescuC Particularitățile clinice și paraclinice la pacienții hipertensivi cu feocromocitom – studiu retrospectiv Rom J Cardiol 2012 22 2 Search in Google Scholar

16 Radojkovic D, Stojanovic M, Pesic M, Radojkovic M, Radenkovic S, et al. Clinically “silent” giant pheochromocytoma. case report. Acta Endocrinologica (BUC) 2013;9(1):121–29. RadojkovicD StojanovicM PesicM RadojkovicM RadenkovicS Clinically “silent” giant pheochromocytoma case report. Acta Endocrinologica (BUC) 2013 9 1 121 29 10.4183/aeb.2013.121 Search in Google Scholar

17 Skov J, Sundstrom A, Ludvigsson JF, Kampe O, Bensing S. Sex-specific risk of cardiovascular disease in autoimmune addison disease – a population-based cohort study. J Clin Endocrinol Metab 2019;104(6):2031–40. SkovJ SundstromA LudvigssonJF KampeO BensingS Sex-specific risk of cardiovascular disease in autoimmune addison disease – a population-based cohort study J Clin Endocrinol Metab 2019 104 6 2031 40 10.1210/jc.2018-02298646922630608542 Search in Google Scholar

18 Rahvar AH, Haas CS, Danneberg S, Harbeck B. Increased cardiovascular risk in patients with adrenal insufficiency: a short review. Biomed Res Int 2017;2017:3691913. RahvarAH HaasCS DannebergS HarbeckB Increased cardiovascular risk in patients with adrenal insufficiency: a short review Biomed Res Int 2017 2017 3691913 10.1155/2017/3691913574244629376070 Search in Google Scholar

19 Schumacher MM, Larsen TR, Sane DC. Cardiac manifestations of adrenal insufficiency. Rev Cardiovasc Med. 2016;17(3–4):131–36. SchumacherMM LarsenTR SaneDC Cardiac manifestations of adrenal insufficiency Rev Cardiovasc Med. 2016 17 3–4 131 36 10.3909/ricm082028144020 Search in Google Scholar

20 Henry M, Kevin GFT, Ian LR, Sleep, cognition and cortisol in Addison's disease: a mechanistic relationship. Front Endocrinol (Lausanne) 2021;12:694046. HenryM KevinGFT IanLR Sleep, cognition and cortisol in Addison's disease: a mechanistic relationship Front Endocrinol (Lausanne) 2021 12 694046 10.3389/fendo.2021.694046842990534512546 Search in Google Scholar